These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 19365530)

  • 1. Improvement of cardiovascular risk factors and cosmetic side effects in kidney transplant recipients after conversion to tacrolimus.
    Zadrazil J; Horak P; Zahalkova J; Strebl P; Horcicka V; Krejci K; Bachleda P; Dedochova J; Valkovsky I
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2009 Mar; 153(1):67-73. PubMed ID: 19365530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Open prospective multicenter study of conversion to tacrolimus therapy in renal transplant patients experiencing ciclosporin-related side-effects.
    Margreiter R; Pohanka E; Sparacino V; Sperschneider H; Kunzendorf U; Huber W; Lameire N; Andreucci VE; Donati D; Heemann U;
    Transpl Int; 2005 Jul; 18(7):816-23. PubMed ID: 15948861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conversion to tacrolimus once-daily from ciclosporin in stable kidney transplant recipients: a multicenter study.
    Rostaing L; Sánchez-Fructuoso A; Franco A; Glyda M; Kuypers DR; Jaray J
    Transpl Int; 2012 Apr; 25(4):391-400. PubMed ID: 22211928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conversion from Neoral (cyclosporine) to tacrolimus of kidney transplant recipients for gingival hyperplasia or hypertrichosis.
    Busque S; Demers P; St-Louis G; Boily JG; Tousignant J; Lemieux F; Smeesters C; Corman J; Daloze P
    Transplant Proc; 1998 Jun; 30(4):1247-8. PubMed ID: 9636507
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hypertrichosis and gingival hypertrophy regression in renal transplants following the substitution of cyclosporin by tacrolimus].
    Busque S; Demers P; Saint-Louis G; Boily JG; Tousignant J; Lemieux F; Martin G; Smeesters C; Corman J; Daloze P
    Ann Chir; 1999; 53(8):687-9. PubMed ID: 10584376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved attainment of NKF classified lipid target levels after conversion from cyclosporine to tacrolimus in renal graft recipients.
    Pohanka E; Margreiter R; Sparacino V; Sperschneider H;
    Transplant Proc; 2005 May; 37(4):1874-6. PubMed ID: 15919490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of conversion from cyclosporine to tacrolimus on gingival hyperplasia, hirsutism and cholesterol.
    Thorp M; DeMattos A; Bennett W; Barry J; Norman D
    Transplantation; 2000 Mar; 69(6):1218-20. PubMed ID: 10762229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, multicenter comparison of tacrolimus and cyclosporine immunosuppressive regimens in cardiac transplantation: decreased hyperlipidemia and hypertension with tacrolimus.
    Taylor DO; Barr ML; Radovancevic B; Renlund DG; Mentzer RM; Smart FW; Tolman DE; Frazier OH; Young JB; VanVeldhuisen P
    J Heart Lung Transplant; 1999 Apr; 18(4):336-45. PubMed ID: 10226898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conversion to tacrolimus to ameliorate cyclosporine toxicity in kidney recipients.
    Burrows L; Knight R; Genyk Y; Schwartz B; Moran V; Anand R
    Transplant Proc; 1998 Aug; 30(5):2030-2. PubMed ID: 9723378
    [No Abstract]   [Full Text] [Related]  

  • 10. Conversion from cyclosporine to tacrolimus in renal transplant recipients with gum hyperplasia.
    Kohnle M; Lütkes P; Zimmermann U; Philipp T; Heemann U
    Transplant Proc; 1999 Nov; 31(7A):44S-45S. PubMed ID: 10576043
    [No Abstract]   [Full Text] [Related]  

  • 11. Conversion from cyclosporine microemulsion to tacrolimus in stable kidney transplant patients with hypercholesterolemia is related to an improvement in cardiovascular risk profile: a prospective study.
    Marcén R; Chahin J; Alarcón A; Bravo J
    Transplant Proc; 2006 Oct; 38(8):2427-30. PubMed ID: 17097957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conversion of cyclosporine A to tacrolimus following heart transplantation.
    Mathieu P; Carrier M; White M; Pellerin M; Perrault LP; Pelletier G; Pelletier LC
    Can J Cardiol; 1999 Nov; 15(11):1229-32. PubMed ID: 10579737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two-year experience with tacrolimus in renal transplantation after late conversion from cyclosporine therapy.
    Videla CO
    Transplant Proc; 2009; 41(6):2659-63. PubMed ID: 19715995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular risk profile after conversion from cyclosporine A to tacrolimus in stable renal transplant recipients.
    Baid-Agrawal S; Delmonico FL; Tolkoff-Rubin NE; Farrell M; Williams WW; Shih V; Auchincloss H; Cosimi AB; Pascual M
    Transplantation; 2004 Apr; 77(8):1199-202. PubMed ID: 15114085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conversion from cyclosporine A to tacrolimus after kidney transplantation due to hyperlipidemia.
    Kohnle M; Zimmermann U; Lütkes P; Albrecht KH; Philipp T; Heemann U
    Transpl Int; 2000; 13 Suppl 1():S345-8. PubMed ID: 11112029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conversion of cyclosporine to tacrolimus in stable renal allograft recipients: quantification of effects on the severity of gingival enlargement and hirsutism and patient-reported outcomes.
    Walker RG; Cottrell S; Sharp K; Tripodi R; Nicholls KM; Fraser I; Varigos GA; Butcher BE
    Nephrology (Carlton); 2007 Dec; 12(6):607-14. PubMed ID: 17995589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elective conversion of patients from cyclosporine to tacrolimus for hypertrichosis.
    Fernando ON; Sweny P; Varghese Z
    Transplant Proc; 1998 Jun; 30(4):1243-4. PubMed ID: 9636505
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical experience of conversion from cyclosporine to tacrolimus prolonged-release in stabilized kidney transplant patients.
    Krejci K; Zadrazil J; Lackova E; Zilinska Z; Roland R; Dedinska I
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Sep; 160(3):407-11. PubMed ID: 27174195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steroid-free immunosuppression in kidney transplant recipients and prograf monotherapy: an interim analysis of a prospective multicenter trial.
    Bäckman L; Aselius H; Lindberger K; Svensson L; Strömbom U; Olausson E; Hadimeri H; Deurell SI; Norrby J; Gäbel M; Ebermark A; Olausson M
    Transplant Proc; 2006 Oct; 38(8):2654-6. PubMed ID: 17098029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of cyclosporine-related adverse effects by conversion to tacrolimus after liver transplantation.
    Pratschke J; Neuhaus R; Tullius SG; Haller GW; Jonas S; Steinmueller T; Bechstein WO; Neuhaus P
    Transplantation; 1997 Sep; 64(6):938-40. PubMed ID: 9326428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.